JIP
AZN icon

Jaffetilchin Investment Partners’s AstraZeneca AZN Stock Holding History

Jaffetilchin Investment Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$207K Sell
1,048
-43
-4% -$8.29K 0.01% 440
2025
Q4 		$201K Buy
+1,091
New +$191K 0.01% 445
2024
Q4 		– Sell
-885
Closed -$138K – 449
2024
Q3 		$138K Buy
+885
New +$143K 0.01% 413

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Jaffetilchin Investment Partners's AZN Position: Q1 2026 in Review

Jaffetilchin Investment Partners reduced its AstraZeneca (AZN) stake by 3.9% in Q1 2026, selling an estimated $8.29K and leaving 1,048 shares worth $207K. The position accounts for 0.01% of the portfolio, ranked #440.

Jaffetilchin Investment Partners first reported a position in AZN in Q3 2024 and has held it in 3 quarters since. 1,381 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Jaffetilchin Investment Partners held 1,048 shares of AstraZeneca worth $207K as of Q1 2026.
  • Jaffetilchin Investment Partners sold 43 AstraZeneca shares in Q1 2026, an estimated $8.29K.
  • AstraZeneca made up 0.01% of Jaffetilchin Investment Partners's portfolio in Q1 2026, its #440 holding.
  • Jaffetilchin Investment Partners first reported a position in AstraZeneca in Q3 2024 and has held it in 3 quarters since.
  • 1,381 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Jaffetilchin Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.